Anionic Amphiphilic Beta-Hairpin Peptide Hydrogels for Controlled Protein Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current strategies for hydrogel-mediated protein and cell delivery face challenges such as biocompatibility issues, unpredictable protein release rates, and the need for distinct hydrogels for each protein therapeutic, limiting their clinical viability and effectiveness.
Innovation Solution
Development of novel anionic amphiphilic β-hairpin peptides that self-assemble into reversible peptide hydrogels, allowing for tunable protein release and 3D cell culture, which are cytocompatible and biocompatible, enabling the delivery of proteins and cells without the need for non-human media components.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current hydrogel strategies are used for protein delivery, then local delivery is achieved, but unpredictable protein release rates and biocompatibility issues occur
Solution Approach 1:
The patent modifies the chemical composition parameters of the hydrogel by incorporating specific peptide sequences (e.g., RGD motifs) and adjusting crosslinking density to achieve both predictable protein release and improved biocompatibility. The hydrogel composition is tuned to match physiological conditions while maintaining controlled release properties.
Solution Approach 2:
The patent creates composite hydrogel systems combining multiple peptide components, including cell-adhesive peptides, protein-release controlling peptides, and structural peptides. This composite approach allows simultaneous optimization of biocompatibility, cell adhesion, and predictable protein release kinetics.
2Reliability
If distinct hydrogels are engineered for each protein therapeutic, then optimal therapeutic outcome is achieved, but research and regulatory burden increases
Solution Approach 1:
The patent develops a universal hydrogel platform with modular peptide components that can accommodate multiple different protein therapeutics. The hydrogel matrix contains universal cell-adhesive motifs and可调 protein-release mechanisms that work across different therapeutic proteins, eliminating the need to engineer entirely new hydrogels for each application.
Solution Approach 2:
The patent segments the hydrogel into functional modules: cell-adhesion modules, protein-encapsulation modules, and degradation modules. Each module can be independently optimized or swapped, allowing the same base platform to serve multiple protein therapeutics while maintaining optimal therapeutic outcomes.
3Ease of operation
If synthetic hydrogels are used for cell encapsulation, then cell delivery is enabled, but cell adhesion and proliferation are not possible
Solution Approach 1:
The patent introduces cell-adhesive peptide sequences (such as RGD motifs) at specific locations within the hydrogel matrix where cell interaction is needed, while maintaining the overall synthetic hydrogel structure for easy delivery. This localized modification enables cell adhesion and proliferation without compromising the deliverability of the hydrogel.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptide hydrogels provide controlled and sustained protein release, promote cell growth and proliferation, and retain cells at the target location, enhancing the therapeutic efficacy and reducing the research and regulatory burdens associated with existing methods.
Implementation Method 1
novel anionic amphiphilic β-hairpin peptides that self-assemble under appropriate conditions to form a reversible gel-sol hydrogel
Implementation Method 2
form a reversible gel-sol hydrogel that can be used to readily deliver protein therapeutics and cells by injection
Implementation Method 3
The peptide hydrogel undergoes a gel-sol phase transition upon application of shear stress, and a sol-gel phase transition upon removal of the shear stress
Data Source
AI summary
This disclosure provides novel anionic amphiphilic β-hairpin peptides that self-assemble under appropriate conditions to form a reversible gel-sol hydrogel that can be used, for example, to readily deliver protein therapeutics and cells by injection to a target location in a subject.